MACROGENICS INC. - COMMON STOCK

NetDania - New 12 months Low: MACROGENICS INC. - COMMON STOCK

11 2月 2025 09:45:20 条件 NetDania Notify

NetDania - New 12 months Low: MACROGENICS INC. - COMMON STOCK

10 2月 2025 09:45:30 条件 NetDania Notify

NetDania - New 12 months Low: MACROGENICS INC. - COMMON STOCK

07 2月 2025 09:46:30 条件 NetDania Notify

NetDania - New 12 months Low: MACROGENICS INC. - COMMON STOCK

06 2月 2025 13:29:26 条件 NetDania Notify

NetDania - New 12 months Low: MACROGENICS INC. - COMMON STOCK

04 2月 2025 09:45:33 条件 NetDania Notify

NetDania - New 12 months Low: MACROGENICS INC. - COMMON STOCK

03 2月 2025 09:45:28 条件 NetDania Notify

NetDania - New 12 months Low: MACROGENICS INC. - COMMON STOCK

21 1月 2025 10:11:05 条件 NetDania Notify

NetDania - New 12 months Low: MACROGENICS INC. - COMMON STOCK

17 1月 2025 11:37:17 条件 NetDania Notify

MacroGenics to Participate in Upcoming Investor Conference

02 12月 2024 16:30:00 条件 Nasdaq GlobeNewswire

MacroGenics to Participate in Upcoming Investor Conferences

06 11月 2024 16:30:00 条件 Nasdaq GlobeNewswire

MacroGenics Provides Update on Corporate Progress, Third Quarter 2024 Financial Results

05 11月 2024 16:01:00 条件 Nasdaq GlobeNewswire

MacroGenics Announces Leadership Transition

30 10月 2024 07:30:00 条件 Nasdaq GlobeNewswire

MacroGenics Announces Date of Third Quarter 2024 Financial Results Conference Call

29 10月 2024 16:30:00 条件 Nasdaq GlobeNewswire

NetDania - New 12 months Low: MACROGENICS INC. - COMMON STOCK

24 9月 2024 09:46:10 条件 NetDania Notify

NetDania - New 12 months Low: MACROGENICS INC. - COMMON STOCK

23 9月 2024 10:42:43 条件 NetDania Notify

MacroGenics Announces Updated Efficacy & Safety Data from TAMARACK Phase 2 Study of Vobra Duo in mCRPC Patients at ESMO Congress 2024

15 9月 2024 03:00:00 条件 Nasdaq GlobeNewswire

MacroGenics Announces TAMARACK Phase 2 Data Presentation at ESMO Congress 2024

08 9月 2024 19:10:00 条件 Nasdaq GlobeNewswire

MacroGenics Provides Update on Corporate Progress, Second Quarter 2024 Financial Results

06 8月 2024 16:01:41 条件 Nasdaq GlobeNewswire

MacroGenics Provides Vobramitamab Duocarmazine Update

30 7月 2024 16:10:00 条件 Nasdaq GlobeNewswire

MacroGenics Announces Achievement of $100 Million in Milestones Related to Retifanlimab Collaboration with Incyte

30 7月 2024 16:01:00 条件 Nasdaq GlobeNewswire